ClinConnect ClinConnect Logo
Search / Trial NCT04436042

MyHand 2: An Active Hand Orthosis for Stroke Patients

Launched by COLUMBIA UNIVERSITY · Jun 15, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Stroke Rehabilitation Hemiparesis Robotics

ClinConnect Summary

The MyHand 2 clinical trial is testing a special device designed to help stroke patients improve the use of their hands. This device, called an active hand orthosis, aims to make daily activities easier for those who have experienced weakness in their hands after a stroke. The researchers are gathering feedback from users to make the device better and more user-friendly.

To participate in the trial, you need to be at least 18 years old and have had a stroke at least six months ago. You should have some weakness in one hand that makes it hard to do everyday tasks, but you must also be able to move your fingers and follow instructions. The trial is open to all genders, and it’s currently looking for participants. If you join, you can expect to help improve this innovative device, potentially making a significant difference for yourself and others in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults over 18 years old
  • History of stroke(s) with most recent stroke at least six months ago
  • Upper extremity weakness with impaired ability to complete daily activities with affected hand
  • Full passive range of motion in all digits
  • Intact cognition to follow directions
  • Gross control of proximal upper extremity musculature
  • Exclusion Criteria:
  • Other neurological conditions besides stroke
  • Other orthopedic conditions to affected upper extremity
  • Significant spasticity in affected upper extremity that impairs device fit

About Columbia University

Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.

Locations

New York, New York, United States

New York City, New York, United States

Patients applied

0 patients applied

Trial Officials

Joel Stein

Principal Investigator

Columbia University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials